Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Fathers
Glycogen Storage Disease Type VII
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate.
Receptors, Lysophospholipid
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets.
Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Proc Natl Acad Sci U S A. 1985 Nov; 82(21):7434-8.
View in:
PubMed
subject areas
Blood Platelets
Cell Fractionation
Cholic Acids
Chromatography, Gel
Humans
Receptors, Cell Surface
Receptors, Prostaglandin
Receptors, Thromboxane
Receptors, Thromboxane A2, Prostaglandin H2
Solubility
Thromboxane A2
authors with profiles
Perry V. Halushka